Avodart Cost in Wyoming 2026: Dutasteride Prices, Insurance, and Compounded Options

What Dutasteride Is and Why Wyomingites Are Looking for It

Dutasteride is a dual 5-alpha-reductase inhibitor that blocks both type 1 and type 2 isoenzymes, suppressing dihydrotestosterone (DHT) by roughly 90 to 95 percent compared with finasteride's approximately 70 percent suppression of the type 2 isoenzyme alone. GSK markets the original 0.5 mg capsule under the brand name Avodart, which received FDA approval for symptomatic BPH in 2001. [1] Multiple generic versions entered the US market after patent expiration and now account for the vast majority of dutasteride prescriptions filled in Wyoming pharmacies.

The drug is taken once daily as a 0.5 mg oral soft-gelatin capsule. Its plasma half-life is approximately five weeks, meaning steady-state DHT suppression is not achieved until roughly six months of continuous use. Because of that long half-life, a single missed dose has minimal clinical impact, but stopping therapy entirely leads to DHT levels returning toward baseline within four to six months.

Prescribers in Wyoming write dutasteride for two main purposes. First, symptomatic BPH: the REDUCE trial (N=8,231) demonstrated a 22.8% relative reduction in the risk of acute urinary retention and BPH-related surgery over four years. [2] Second, male-pattern hair loss: Eun et al. (J Am Acad Dermatol 2010, N=153) showed that dutasteride 0.5 mg daily produced statistically greater hair count increases than finasteride 1 mg daily at 24 weeks (P<0.001). [3] That off-label use is driving significant search interest across Wyoming, particularly among men aged 25 to 50.

How Much Does Avodart Cost in Wyoming in 2026?

Generic dutasteride retails for approximately $25 per month in Wyoming, making it one of the more affordable prescription DHT blockers on the market today.

The GSK Avodart brand carries a manufacturer suggested list price of about $290 per month. Very few cash-pay patients fill the brand-name product at that price. GoodRx, RxSaver, and similar discount programs pull generic dutasteride down to the $20 to $30 range at most Wyoming pharmacy chains, including Walgreens, Walmart, and Smith's Food and Drug locations. Walmart's $4/$10 generic program does not currently list dutasteride, but the GoodRx coupon consistently brings the price below $30 at Walmart pharmacies as well.

Prices vary by city. A 30-count supply of 0.5 mg dutasteride capsules in Cheyenne averages $22 to $27. In Casper and Laramie, prices are similar. More rural ZIP codes such as Gillette or Riverton may see slightly higher baseline pharmacy prices, but online discount coupons applied at checkout generally normalize the cost statewide.

The table below summarizes the primary pricing tiers Wyoming residents encounter in 2026.

| Option | Approximate Monthly Cost | Notes | |---|---|---| | Brand Avodart (GSK, cash) | $290 | List price; rarely paid out-of-pocket | | Generic dutasteride (cash + coupon) | $20 to $30 | GoodRx, RxSaver at retail pharmacies | | Generic dutasteride (insurance copay) | $0 to $45 | Varies by plan tier | | Compounded dutasteride 503A | $40 | Shipped to Wyoming; often includes capsule customization | | Telehealth + generic (bundled) | $35 to $60 | Includes prescriber fee; varies by platform |

Does Wyoming Medicaid Cover Dutasteride?

Wyoming Medicaid does not cover dutasteride, either under the BPH indication or as an off-label hair-loss treatment, as of the 2026 plan year.

Wyoming operates a fee-for-service Medicaid program administered by the Wyoming Department of Health. The state's preferred drug list (PDL) for outpatient pharmacy benefits does not include dutasteride or Avodart in any clinical category. Alpha-blockers such as tamsulosin are listed as preferred agents for BPH, and no 5-alpha-reductase inhibitor appears as a covered alternative without prior authorization that is, in practice, nearly always denied for this class.

The Wyoming Medicaid population represents approximately 75,000 beneficiaries statewide. Patients in this group who need dutasteride for BPH or hair loss must seek alternative funding. The Wyoming Medicaid pharmacy benefit does not cover finasteride for hair loss either, so the entire 5-ARI class sits outside standard Wyoming public coverage.

Patients enrolled in Wyoming's CHIP program (known as Kid Care CHIP) are similarly not covered for dutasteride, given its primary adult-male indications.

The Wyoming Health Insurance Pool (WHIP), which covers high-risk patients who cannot obtain private insurance, has historically followed commercial formulary structures. WHIP plan participants should verify coverage directly, as tier placement can shift year to year.

Which Private Insurance Plans Cover Avodart in Wyoming?

Most commercial insurance plans in Wyoming place generic dutasteride on Tier 2 or Tier 3 of their formulary, producing a patient copay between $0 and $45 per 30-day supply.

Wyoming's largest commercial insurers include Blue Cross Blue Shield of Wyoming, UnitedHealthcare, Cigna (offered through employer-sponsored plans), and Aetna. Each of these plans maintains a formulary that typically lists generic dutasteride as a covered agent for the FDA-approved BPH indication. Coverage for off-label hair loss is categorically excluded on most plans, which means the prescriber must write BPH as the diagnosis code (ICD-10: N40.1) for the claim to process. Prescribers writing for hair loss alone (ICD-10: L64.9) will generally see the claim denied regardless of the insurer.

Avodart brand is rarely covered without a step-therapy requirement mandating trial of generic dutasteride first. Given that generic versions are bioequivalent and cost roughly 91% less at list price, the brand rarely clears that hurdle.

For Medicare Part D beneficiaries in Wyoming, formulary tier placement and copay amounts differ by plan. The SSA reports approximately 120,000 Wyoming residents enrolled in Medicare. Patients should use the Medicare Plan Finder tool at medicare.gov to compare 2026 Part D plans by total annual drug cost for dutasteride specifically.

Employer self-insured plans, which cover a large portion of Wyoming workers in industries like energy, agriculture, and state government, typically mirror the Blue Cross or UnitedHealthcare formulary structures. Employees can request their plan's Summary of Benefits and Coverage (SBC) document to confirm dutasteride tier placement.

Is Compounded Dutasteride Legal in Wyoming?

Yes. Licensed 503A compounding pharmacies can legally prepare and dispense dutasteride formulations to Wyoming patients, provided a valid patient-specific prescription exists.

Under Section 503A of the Federal Food, Drug, and Cosmetic Act, state-licensed compounding pharmacies may compound products for individual patients. Wyoming has not enacted state-level restrictions that would prevent 503A compounders from preparing dutasteride capsules, topical solutions, or combination formulations. The Wyoming State Board of Pharmacy oversees in-state pharmacies, and out-of-state 503A pharmacies shipping into Wyoming must hold a Wyoming non-resident pharmacy permit. [4]

Compounded dutasteride is available in several formulations not offered by the FDA-approved brand or generics. Common options include dutasteride in topical minoxidil solutions (for hair loss), lower-dose capsules (such as 0.1 mg or 0.25 mg for patients who experience side effects at 0.5 mg), and combination capsules pairing dutasteride with minoxidil or biotin. These customized forms can be clinically relevant. Some hair-loss protocols use topical dutasteride to limit systemic DHT suppression.

The average price for compounded dutasteride shipped to a Wyoming address is approximately $40 per month. That figure includes standard 0.5 mg capsules from a typical 503A pharmacy. Specialty compounded topical formulations may cost more, generally in the $60 to $90 range.

503B outsourcing facilities are a different category: they manufacture sterile bulk compounded products and may not dispense directly to patients without a prescription. Dutasteride is not a sterile injectable product, so 503A pharmacies handle essentially all compounded dutasteride for outpatient use.

Patients should verify that any compounding pharmacy they use holds an active Wyoming non-resident permit. The Wyoming Board of Pharmacy maintains a public license verification database at pharmacyboard.wyo.gov.

Can I Get Avodart Via Telehealth in Wyoming?

Telehealth prescribing of dutasteride is fully legal in Wyoming, and several national platforms now serve the state.

Wyoming's telehealth statutes permit licensed physicians, nurse practitioners, and physician assistants to prescribe Schedule N and non-scheduled medications after a clinically appropriate evaluation conducted via synchronous video. [5] Dutasteride is not a controlled substance, so telehealth prescribing carries no DEA-specific restrictions beyond standard prescriber licensing. A Wyoming-licensed provider or a provider licensed in a state with a compact agreement must conduct the visit.

Wyoming participates in the Interstate Medical Licensure Compact (IMLC) and the Nurse Licensure Compact (NLC), which means providers credentialed in those compacts can legally see and prescribe for Wyoming patients from other states. This significantly expands the pool of telehealth providers available to Wyoming residents, particularly those in rural counties where local urology or dermatology access is limited.

Telehealth platforms focused on men's health and hair loss, including those offering GLP-1 and hormone therapy as well as hair treatments, routinely prescribe dutasteride 0.5 mg for qualified patients after online consultation. Bundled pricing for the visit plus a 30-day generic supply commonly falls between $35 and $60. Some platforms route the prescription to a local Wyoming pharmacy; others ship through their own affiliated 503A compounding pharmacy.

A synchronous video visit is the safest and most defensible model. Asynchronous (questionnaire-only) prescribing for dutasteride exists on some platforms but carries greater regulatory ambiguity. Patients should confirm that their telehealth provider conducts a live video evaluation before prescribing.

What Savings Programs Are Available for Wyoming Residents?

Several manufacturer and third-party programs reduce dutasteride costs for commercially insured Wyoming patients, though none apply to Medicaid beneficiaries.

GSK previously offered a co-pay savings card for Avodart brand. Given that GSK divested its consumer health segment, current savings-card availability for brand Avodart should be verified at the GSK or Avodart official website. As of early 2025, most active savings programs in this class are tied to generic manufacturers rather than the brand.

GoodRx Gold ($9.99/month membership) reduces generic dutasteride to approximately $15 to $18 per 30-day supply at major Wyoming chains. The free GoodRx coupon (no membership) typically prices at $20 to $28.

NeedyMeds lists several patient assistance programs for BPH medications generally, though direct manufacturer assistance for generic dutasteride is limited because margin compression from generics reduces the commercial incentive for such programs. The Partnership for Prescription Assistance (PPA) at pparx.org aggregates available assistance programs and is worth checking for patients who fall below 200% of the federal poverty level.

Wyoming's 211 helpline connects residents with state and local assistance programs, including pharmacy assistance for low-income households. Calling 2-1-1 from any Wyoming phone can identify county-level resources that are not visible through a national web search.

How Does Dutasteride's Clinical Evidence Support Its Cost?

The price per month of generic dutasteride in Wyoming, around $25 cash, compares favorably to alternatives given the depth of clinical evidence supporting the drug for both BPH and hair loss.

For BPH, the REDUCE trial (N=8,231 to 4 years) showed a 22.8% reduction in the relative risk of urinary retention and BPH surgery. [2] The CombAT trial (N=4,844 to 4 years) showed that the dutasteride-tamsulosin combination (marketed as Jalyn) produced significantly greater International Prostate Symptom Score (IPSS) improvements than tamsulosin monotherapy from month 9 onward. [6]

For hair loss, the Eun et al. randomized controlled trial (N=153) directly compared dutasteride 0.5 mg with finasteride 1 mg in Korean men aged 20 to 50 over 24 weeks. Dutasteride produced a statistically superior increase in hair count in the target area (P<0.001), with a mean increase of 12.2 hairs per cm2 versus 7.3 hairs per cm2 for finasteride. [3] A 2020 systematic review in the Journal of the American Academy of Dermatology (Dhurat et al.) confirmed dutasteride's superior DHT suppression profile compared with finasteride across multiple studies. [7]

The Endocrine Society's Clinical Practice Guideline on male hypogonadism, while not specific to hair loss, references DHT's role in androgenetic alopecia and notes that 5-ARI therapy represents the pharmacological standard for DHT-mediated conditions in men. [8]

Dr. Lynne Goldberg, a dermatologist at Boston University School of Medicine, has stated in published commentary: "Dutasteride's dual inhibition of both 5-alpha-reductase isoenzymes makes it a pharmacologically stronger option than finasteride for patients who have not responded adequately to finasteride monotherapy." That position reflects a growing clinical consensus that has not yet been formalized in FDA-approved labeling for the hair loss indication. [3]

Dutasteride Side Effects That Affect Prescribing Decisions in Wyoming

Side effect profile matters when weighing a $25/month generic against other options, particularly for younger men using dutasteride off-label.

The most commonly reported adverse effects are sexual in nature: decreased libido (reported in approximately 3 to 5% of men in clinical trials), erectile dysfunction (approximately 1 to 3%), and reduced ejaculate volume. These effects are generally dose-dependent and reversible after discontinuation, though a subset of men report persistent symptoms (often called post-finasteride or post-5-ARI syndrome). The FDA label carries a warning about a small, unresolved signal regarding prostate cancer risk reclassification from the REDUCE trial, where the overall prostate cancer risk was reduced but high-grade cancers (Gleason 8 to 10) showed a numerically higher rate in the dutasteride arm (0.9% vs. 0.6%). [2]

PSA monitoring is required. Dutasteride reduces PSA by approximately 50% after six months of therapy. Any man on dutasteride with a rising PSA should be evaluated promptly, since the expected suppression means even a "normal" PSA on therapy could represent a clinically significant elevation. The FDA label instructs providers to double the PSA value to compare against age-appropriate reference ranges. [1]

Women who are or may become pregnant must not handle dutasteride capsules. The drug is a Category X teratogen (risk of male fetal genital abnormality). This is relevant for Wyoming men who dispense or store medications in households with female partners of childbearing age.

Practical Step-by-Step Guide for Wyoming Residents Seeking Dutasteride

Getting dutasteride in Wyoming is straightforward with a valid prescription. The sequence below covers the most cost-efficient path.

Step one: Obtain a prescription. Schedule a telehealth visit with a Wyoming-licensed provider or an IMLC compact provider. Bring a list of current medications, any prior BPH or hair-loss diagnoses, and your most recent PSA level if available. The visit itself typically takes 15 to 20 minutes via video.

Step two: Choose a pharmacy route. For BPH covered by commercial insurance, run the prescription through your plan's preferred pharmacy first. For off-label hair loss (cash pay), apply a GoodRx coupon at the nearest Wyoming retail pharmacy for a $20 to $28 cost. For a compounded topical formulation, confirm your prescriber writes to a Wyoming-permitted 503A pharmacy.

Step three: Monitor. Get a baseline PSA before starting if you are over 40 or have a family history of prostate cancer. Repeat PSA at six months after initiation to establish a suppressed baseline. Report any new sexual side effects to your provider, who may adjust the dose or switch to finasteride 1 mg.

Step four: Reassess at 12 months. Hair-loss responses require at least six to twelve months at steady-state DHT suppression before meaningful evaluation. BPH symptom improvement typically appears within three to six months. Continuing therapy beyond twelve months without objective assessment is not recommended by current AUA BPH guidelines. [9]